Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for AdaptHealth (AHCO) over the last 6 years, with Q3 2025 value amounting to $137.2 million.

  • AdaptHealth's Shares Outstanding (Diluted Average) rose 49.88% to $137.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.2 million, marking a year-over-year increase of 49.88%. This contributed to the annual value of $135.5 million for FY2024, which is 82.8% up from last year.
  • According to the latest figures from Q3 2025, AdaptHealth's Shares Outstanding (Diluted Average) is $137.2 million, which was up 49.88% from $137.2 million recorded in Q2 2025.
  • Over the past 5 years, AdaptHealth's Shares Outstanding (Diluted Average) peaked at $140.3 million during Q3 2021, and registered a low of $132.9 million during Q1 2024.
  • Over the past 5 years, AdaptHealth's median Shares Outstanding (Diluted Average) value was $136.5 million (recorded in 2024), while the average stood at $136.6 million.
  • In the last 5 years, AdaptHealth's Shares Outstanding (Diluted Average) surged by 15345.6% in 2021 and then tumbled by 328.81% in 2023.
  • AdaptHealth's Shares Outstanding (Diluted Average) (Quarter) stood at $133.0 million in 2021, then rose by 4.48% to $139.0 million in 2022, then fell by 3.29% to $134.4 million in 2023, then increased by 0.83% to $135.5 million in 2024, then increased by 1.24% to $137.2 million in 2025.
  • Its last three reported values are $137.2 million in Q3 2025, $137.2 million for Q2 2025, and $134.8 million during Q1 2025.